Cue Biopharma Announces Upcoming Scientific Presentations at the Society for Immunotherapy of Cancer's (SITC) 37th Annual Meeting

(marketscreener.com) BOSTON, Oct. 05, 2022 -- Cue Biopharma, Inc. , a clinical-stage biopharmaceutical company developing a novel class of injectable biologics to selectively engage and modulate tumor-specific T cells directly within the patient’s body, announced today three poster presentations at the Society for Immunotherapy of Cancer’s 37th Annual...https://www.marketscreener.com/quote/stock/CUE-BIOPHARMA-INC-39051301/news/Cue-Biopharma-Announces-Upcoming-Scientific-Presentations-at-the-Society-for-Immunotherapy-of-Cancer-41932866/?utm_medium=RSS&utm_content=20221005